Synthetic peptide vaccine as well as preparation method and application thereof
一种合成肽疫苗、口蹄疫的技术,应用在疫苗及它们的制备,O型口蹄疫合成肽疫苗的多肽或其多肽聚合物领域,能够解决不能有效地保护动物、效果差、影响新型疫苗使用等问题,达到良好应用前景、增强免疫效果、易于大规模合成的效果
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1、 Embodiment 1
[0040] Embodiment 1, the solid-phase synthesis of embodiment 1 foot-and-mouth disease synthetic peptide antigen
[0041]The present invention studies the variation of the main antigenic sites of the FMD by determining the sequence of the newly popular strains of the domestic FMD and combining the sequences of the MYA / 98 and OZK / 93 vaccine strains of the FMD, and counts the variation frequency of the main mutated amino acid sites , combined with computer-aided analysis and prediction of antigenic sites of FMD, chemically synthesized peptides of possible antigenic sites, that is, according to the statistical variation frequency of variable sites, different amino acids are used in these sites to obtain coverage of the current Multiple candidate peptide antigens for all possible variant sites. Further, these candidate polypeptide antigens are screened through a large number of animal experiments, and the polypeptide antigens that can cause the immune response of animals, and have ...
Embodiment 2
[0072] Embodiment 2, the preparation of synthetic peptide vaccine
[0073] 1. Preparation of antigen aqueous phase
[0074] First, weigh the three peptide antigens synthesized according to the above-mentioned Example 1; then, dilute the concentration of the synthesized peptide antigen to 50 μg / ml with sterile water for injection; filter the antigen solution through a filter with a pore size of 0.2 μm, and sterilize .
[0075] 2. Preparation of oil phase adjuvant
[0076] Sterilize the oil phase adjuvant ISA50V at 121°C for 30 minutes, and set aside.
[0077] 3. Emulsion of synthetic peptide vaccine
[0078] Wash the IKA emulsification equipment (purchased from IKA Company, product number 200603) with 2000ml of sterilized distilled water for 3 times, and then under the condition of 20-28°C, the oil phase adjuvant and the antigen water phase are in a volume ratio of 1:1, and the oil Add the phase into the emulsification tank, start the motor and stir at a slow speed of 90-15...
Embodiment 3
[0079] Embodiment 3, efficacy test of synthetic peptide vaccine
[0080] 1. Materials and methods
[0081] 1. Synthetic peptide vaccine
[0082] Synthesize polypeptide antigens having the sequences of SEQ ID NO: 1, SEQ ID NO: 2, and SEQ ID NO: 3 according to the above-mentioned Example 1. The sulfhydryl groups of the two cysteines of these polypeptides are oxidized and linked together to form a disulfide bond, and The reaction between the carboxyl and hydroxyl groups of the head and tail amino acids forms a covalent linkage. These are then prepared respectively according to the method of embodiment 2 and corresponding batch number is: the foot-and-mouth disease O type synthetic peptide vaccine of ZM433A01, ZM433A02, ZM433A03.
[0083] In addition, all the valines in the amino acid sequence in SEQ ID NO: 1 were replaced with norvaline; all the leucines were replaced with norleucine, and the antigen was synthesized according to the method provided in the above examples, and th...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com